Cargando…

Adapting treatment length to opioid‐dependent individuals’ needs and preferences: a 2‐year follow‐up to a 1‐year study of extended‐release naltrexone

BACKGROUND AND AIMS: Extended‐release naltrexone (XR‐NTX) is an under‐used treatment option for opioid dependence, today only available in a few countries in the world. Although effective, safe and feasible in short‐term treatment, long‐term data are scarce and there is no recommendation for require...

Descripción completa

Detalles Bibliográficos
Autores principales:	Solli, Kristin Klemmetsby, Opheim, Arild, Latif, Zill‐e‐Huma, Krajci, Peter, Benth, Jūratė Šaltytė, Kunoe, Nikolaj, Tanum, Lars
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2021
Materias:	Research Reports
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8359292/ https://www.ncbi.nlm.nih.gov/pubmed/33338285 http://dx.doi.org/10.1111/add.15378

Ejemplares similares

Design of a randomized controlled trial of extended-release naltrexone versus daily buprenorphine-naloxone for opioid dependence in Norway (NTX-SBX)
por: Kunøe, Nikolaj, et al.
Publicado: (2016)

Personal recovery among people with opioid use disorder during treatment with extended-release naltrexone
por: Marciuch, Anne, et al.
Publicado: (2023)

Impact of Impulsivity, Hyperactivity, and Inattention on Discontinuation Rate among Opioid-Dependent Patients Treated with Extended-Release Naltrexone
por: Karlsson, Ann Tarja, et al.
Publicado: (2022)

Levels of Impulsivity, Hyperactivity, and Inattention and the Association with Mental Health and Substance Use Severity in Opioid-Dependent Patients Seeking Treatment with Extended-Release Naltrexone
por: Karlsson, Ann Tarja, et al.
Publicado: (2021)

Patients’ experiences of continued treatment with extended-release naltrexone: a Norwegian qualitative study
por: Marciuch, Anne, et al.
Publicado: (2022)

Enablers and hindrances for longer-term abstinence in opioid dependent individuals receiving treatment with extended-release naltrexone: A Norwegian longitudinal recovery trial (NaltRec study)
por: Weimand, B.M., et al.
Publicado: (2021)

Mortality in nursing home residents: A longitudinal study over three years
por: Vossius, Corinna, et al.
Publicado: (2018)

Mortality and causes of death among patients with opioid use disorder receiving opioid agonist treatment: a national register study
por: Bech, Anne Berit, et al.
Publicado: (2019)

Naltrexone extended-release injection: an option for the management of opioid abuse
por: Taylor, Robert, et al.
Publicado: (2011)

The use of direct care in nursing home residents: A longitudinal cohort study over 3 years
por: Vossius, Corinna, et al.
Publicado: (2018)

Do prescription rates of psychotropic drugs change over three years from nursing home admission?
por: Callegari, Enrico, et al.
Publicado: (2021)

Correction: Do prescription rates of psychotropic drugs change over three years from nursing home admission?
por: Callegari, Enrico, et al.
Publicado: (2022)

The association between geriatric treatment and 30-day readmission risk among medical inpatients aged ≥75 years with multimorbidity
por: Wang-Hansen, Marte Sofie, et al.
Publicado: (2022)

Characteristics and treatment preferences of individuals with opioid use disorder seeking to transition from buprenorphine to extended‐release naltrexone in a residential setting
por: Mannelli, Paolo, et al.
Publicado: (2022)

Treating Opioid Dependence With Injectable Extended-Release Naltrexone (XR-NTX): Who Will Respond?
por: Nunes, Edward V., et al.
Publicado: (2015)

Quality of life of family carers of persons with young-onset dementia: A Nordic two-year observational multicenter study
por: Hvidsten, Lara, et al.
Publicado: (2019)

Beyond the transanal total mesorectal excision moratorium: local and distant recurrence among patients operated for low rectal tumours—5-year follow-up from a Norwegian University Hospital
por: Riis, Rolf N, et al.
Publicado: (2023)

Naltrexone Implant for Opioid Use Disorder
por: Edinoff, Amber N., et al.
Publicado: (2021)

Mortality in nursing home residents stratified according to subtype of dementia: a longitudinal study over three years
por: Vossius, Corinna, et al.
Publicado: (2022)

Patient-controlled admission contracts: a longitudinal study of patient evaluations
por: Nyttingnes, Olav, et al.
Publicado: (2021)

Medication Treatment for Opioid Use Disorders:: A Brief Overview with Comments on Extended Release Naltrexone
por: Woody, George
Publicado: (2017)

Validation of Placebo in a Manual Therapy Randomized Controlled Trial
por: Chaibi, Aleksander, et al.
Publicado: (2015)

Impact of the Sonas Programme on Communication over a Period of 24 Weeks in People with Moderate-to-Severe Dementia
por: Strøm, Benedicte Sørensen, et al.
Publicado: (2018)

Obstetric and psychological characteristics of women choosing epidural analgesia during labour: A cohort study
por: Sitras, Vasilis, et al.
Publicado: (2017)

Levels of mental distress over 18 years after entering treatment for substance use disorders: A longitudinal cohort study
por: Hjemsæter, Arne Jan, et al.
Publicado: (2020)

Open-label Study of Injectable Extended-release Naltrexone (XR-NTX) in Healthcare Professionals With Opioid Dependence
por: Earley, Paul H., et al.
Publicado: (2017)

The relationship between reincarceration and treatment of opioid use disorder with extended-release naltrexone among persons with HIV
por: Parchinski, Kaley, et al.
Publicado: (2023)

Health-related quality of life in older depressed psychogeriatric patients: one year follow-up
por: Helvik, Anne-Sofie, et al.
Publicado: (2016)

The relationship between area levels of involuntary psychiatric care and patient outcomes: a longitudinal national register study from Norway
por: Nyttingnes, Olav, et al.
Publicado: (2023)

Mortality, cause of death and risk factors in patients with alcohol use disorder alone or poly-substance use disorders: a 19-year prospective cohort study
por: Hjemsæter, Arne Jan, et al.
Publicado: (2019)

Epidemiologic and Molecular Pathophysiology of Chronic Opioid Dependence and the Place of Naltrexone Extended-Release Formulations in its Clinical Management
por: Reece, Albert Stuart
Publicado: (2012)

Evaluation of Opioid Overdose Reports in Patients Treated with Extended-Release Naltrexone: Postmarketing Data from 2006 to 2018
por: Jain, Priya, et al.
Publicado: (2020)

Association between body mass index and treatment completion in extended-release naltrexone-treated patients with opioid dependence
por: Li, Xinyi, et al.
Publicado: (2023)

Discrepancy in Ratings of Shared Decision Making Between Patients and Health Professionals: A Cross Sectional Study in Mental Health Care
por: Drivenes, Karin, et al.
Publicado: (2020)

Improved Rehabilitation Outcomes for Persons With and Without Problematic Substance Use After 2 Years With Assertive Community Treatment—A Prospective Study of Patients With Severe Mental Illness in 12 Norwegian ACT Teams
por: Clausen, Hanne, et al.
Publicado: (2020)

Data splitting as a countermeasure against hypothesis fishing: with a case study of predictors for low back pain
por: Dahl, Fredrik A., et al.
Publicado: (2008)

A 52 month follow-up of functional decline in nursing home residents – degree of dementia contributes
por: Helvik, Anne-Sofie, et al.
Publicado: (2014)

Antenatal Maternal Emotional Distress and Duration of Pregnancy
por: Lukasse, Mirjam, et al.
Publicado: (2014)

Time from Symptom Debut to Dementia Assessment by the Specialist Healthcare Service in Norway
por: Helvik, Anne-Sofie, et al.
Publicado: (2018)

Body mass index in nursing home residents during the first year after admission
por: Vossius, Corinna, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_gdkiljnduup5c4k7ds82nf4fmf